Mesothelioma Cancer Resources Blog
-
Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma
Source: Cancer Even as improvements in the therapies available for mesothelioma patients have been made in recent years, the disease remains without cure. Most patients are ineligible for curative surgeries, so investigations into improving the efficacy of chemotherapy are among the most common research programs in contemporary mesothelioma treatment studies. Combination chemotherapy using pemetrexed and …
Label: Chemotherapy Mesothelioma Pleural Mesothelioma Treatments
Posted on Friday, Jul 25, 2008 -
Asbestos burden predicts survival in pleural mesothelioma
Source: Environmental Health Perspectives Researchers have identified a number of factors in a patient’s presentation with mesothelioma that serve as important indicators of the disease’s treatability and overall prognosis. Two of the most significant indicators are the gender of the patient and the histological subtype of the disease. In terms of gender, studies have shown …
Label: Mesothelioma Pleural Mesothelioma
Posted on Friday, Jul 11, 2008 -
Molecular targets and targeted therapies for malignant mesothelioma
Source: Current Medicinal Chemistry Some of the most important work in contemporary mesothelioma research involves the attempt to create targeted therapeutic agents which work directly on the cellular aberrations that are ultimately responsible for the development of pleural mesothelioma and peritoneal mesothelioma. The great hope these therapies inspire is based on the idea that if …
Label: Mesothelioma Treatments
Posted on Tuesday, Jul 1, 2008
Mike is a licensed attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly. He has contributed numerous articles to the North Carolina State Bar Journal and is a co-author of Capital Lawyers, a history of the Wake County (NC) Bar.
Gregory Froom is a licensed North Carolina attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly.